Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy.

Nakata I, Yamashiro K, Yamada R, Gotoh N, Nakanishi H, Hayashi H, Tsujikawa A, Otani A, Ooto S, Tamura H, Saito M, Saito K, Iida T, Oishi A, Kurimoto Y, Matsuda F, Yoshimura N.

Ophthalmology. 2011 Jul;118(7):1408-15. doi: 10.1016/j.ophtha.2010.12.011. Epub 2011 Mar 24.

PMID:
21439646
2.

Lack of association with PEDF Met72Thr variant in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Han Chinese population.

Wu K, Wen F, Zuo C, Li M, Zhang X, Chen H, Zeng R.

Curr Eye Res. 2012 Jan;37(1):68-72. doi: 10.3109/02713683.2011.618289. Epub 2011 Oct 26.

PMID:
22029535
3.
4.

Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.

Sakurada Y, Kubota T, Imasawa M, Mabuchi F, Tateno Y, Tanabe N, Iijima H.

Ophthalmology. 2011 Jul;118(7):1402-7. doi: 10.1016/j.ophtha.2010.12.010. Epub 2011 Mar 12.

PMID:
21397333
5.

Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.

Byeon SH, Lew YJ, Lee SC, Kwon OW.

Acta Ophthalmol. 2010 Sep;88(6):660-8. doi: 10.1111/j.1755-3768.2009.01517.x.

6.

Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.

Kang SW, Chung SE, Shin WJ, Lee JH.

Br J Ophthalmol. 2009 Jun;93(6):759-64. doi: 10.1136/bjo.2008.145862. Epub 2009 Mar 19.

PMID:
19304584
7.

Polypoidal choroidal vasculopathy and treatments.

Gomi F, Tano Y.

Curr Opin Ophthalmol. 2008 May;19(3):208-12. doi: 10.1097/ICU.0b013e3282fb7c33. Review.

PMID:
18408495
8.

Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.

Tsujikawa A, Ojima Y, Yamashiro K, Nakata I, Ooto S, Tamura H, Nakanishi H, Hayashi H, Otani A, Yoshimura N.

Am J Ophthalmol. 2011 Jun;151(6):961-972.e1. doi: 10.1016/j.ajo.2011.01.002. Epub 2011 Mar 31.

9.

Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population.

Mori K, Horie-Inoue K, Gehlbach PL, Takita H, Kabasawa S, Kawasaki I, Ohkubo T, Kurihara S, Iizuka H, Miyashita Y, Katayama S, Awata T, Yoneya S, Inoue S.

Ophthalmology. 2010 May;117(5):928-38. doi: 10.1016/j.ophtha.2009.10.001. Epub 2010 Feb 4.

PMID:
20132989
10.
11.

Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.

Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H.

Retina. 2009 Jul-Aug;29(7):960-5. doi: 10.1097/IAE.0b013e3181a3b7c5.

PMID:
19491727
12.

Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy.

Nakanishi H, Yamashiro K, Yamada R, Gotoh N, Hayashi H, Nakata I, Saito M, Iida T, Oishi A, Kurimoto Y, Matsuo K, Tajima K, Matsuda F, Yoshimura N.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6183-7. doi: 10.1167/iovs.09-4948. Epub 2010 Aug 4.

PMID:
20688737
13.

The long-term data of photodynamic therapy (PDT) for polypoidal choroidal vasculopathy (PCV).

Chhablani JK.

Retina. 2011 Jan;31(1):196-7; author reply 197-8. doi: 10.1097/IAE.0b013e3181fe924f. No abstract available.

PMID:
21187741
14.

Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.

Honda S, Imai H, Yamashiro K, Kurimoto Y, Kanamori-Matsui N, Kagotani Y, Tamura Y, Yamamoto H, Ohoto S, Takagi H, Uenishi M, Negi A.

Ophthalmologica. 2009;223(5):333-8. doi: 10.1159/000221837. Epub 2009 May 29.

PMID:
19478533
15.

Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.

Tsujikawa A, Hirami Y, Nakanishi H, Ojima Y, Aikawa H, Tamura H, Otani A, Yoshimura N.

Retina. 2007 Sep;27(7):832-8.

PMID:
17891005
16.

Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.

Hikichi T, Ohtsuka H, Higuchi M, Matsushita T, Ariga H, Kosaka S, Matsushita R, Takami K.

Am J Ophthalmol. 2010 Nov;150(5):674-682.e1. doi: 10.1016/j.ajo.2010.05.026. Epub 2010 Aug 5.

PMID:
20691424
17.

Polypoidal choroidal vasculopathy: an angiographic discussion.

Lim TH, Laude A, Tan CS.

Eye (Lond). 2010 Mar;24(3):483-90. doi: 10.1038/eye.2009.323. Epub 2010 Jan 15.

PMID:
20075967
18.

The prognosis of cases with massive subretinal hemorrhage after photodynamic therapy.

Matsushita S, Naito T, Takebayashi M, Sato H, Shiota H.

J Med Invest. 2008 Aug;55(3-4):231-5.

19.

Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy.

Ojima Y, Tsujikawa A, Otani A, Hirami Y, Aikawa H, Yoshimura N.

Am J Ophthalmol. 2006 May;141(5):958-60.

PMID:
16678520
20.

Polypoidal choroidal vasculopathy.

Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA.

Surv Ophthalmol. 2004 Jan-Feb;49(1):25-37. Review.

PMID:
14711438

Supplemental Content

Support Center